- Home
- SVA vs LPLA Comparison
SVA vs LPLA Comparison
Compare SVA & LPLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- LPLA
- Stock Information
- Founded
- SVA N/A
- LPLA 1989
- Country
- SVA
- LPLA United States
- Employees
- SVA 3261
- LPLA N/A
- Industry
- SVA
- LPLA Investment Bankers/Brokers/Service
- Sector
- SVA
- LPLA Finance
- Exchange
- SVA NYSE
- LPLA Nasdaq
- Market Cap
- SVA N/A
- LPLA 30.4B
- IPO Year
- SVA N/A
- LPLA 2010
- Fundamental
- Price
- SVA $6.47
- LPLA $373.96
- Analyst Decision
- SVA
- LPLA Buy
- Analyst Count
- SVA 0
- LPLA 14
- Target Price
- SVA N/A
- LPLA $385.36
- AVG Volume (30 Days)
- SVA N/A
- LPLA 677.6K
- Earning Date
- SVA N/A
- LPLA 07-31-2025
- Dividend Yield
- SVA N/A
- LPLA 0.32%
- EPS Growth
- SVA N/A
- LPLA 9.05
- EPS
- SVA N/A
- LPLA 14.44
- Revenue
- SVA N/A
- LPLA $12,896,160,000.00
- Revenue This Year
- SVA N/A
- LPLA $29.44
- Revenue Next Year
- SVA N/A
- LPLA $17.17
- P/E Ratio
- SVA N/A
- LPLA $25.77
- Revenue Growth
- SVA N/A
- LPLA 25.70
- 52 Week Low
- SVA N/A
- LPLA $187.19
- 52 Week High
- SVA N/A
- LPLA $390.23
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- LPLA 49.55
- Support Level
- SVA N/A
- LPLA $374.35
- Resistance Level
- SVA N/A
- LPLA $385.38
- Average True Range (ATR)
- SVA 0.00
- LPLA 10.36
- MACD
- SVA 0.00
- LPLA 0.04
- Stochastic Oscillator
- SVA 0.00
- LPLA 66.55
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About LPLA LPL Financial Holdings Inc.
LPL Financial Holdings is an independent broker/dealer that provides a platform of proprietary technology, brokerage, and investment advisory services to financial advisors and institutions. As of the end of 2024, the company had over 29,000 advisors on its platform managing $1.7 trillion of client assets. The company doesn't have material operations outside the United States.